Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
Release Date:
Partner: American College of Emergency Physicians (ACEP)
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Title
Grant Type
Focus Area
Country
Application Due Date
Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Oncology USA
Optimizing Biomarker-Directed Therapy in Metastatic Colorectal Cancer
Release Date:
Partner: The National Comprehensive Cancer Network®, Fight Colorectal Cancer
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Addressing the Needs of Patients with Mental Health Issues and Dermatological Inflammatory Conditions
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Rare Disease Canada
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA
Improving Treatment Environment and Survivorship for Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Improving Treatment Environment and Survivorship for Leukemia
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Advances in the Management of Ulcerative Colitis (UC) (Europe, Canada, Japan, South Korea, Australia, New Zealand, Israel)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Increasing Awareness and Understanding of Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Shared Decision-Making (SDM) for Patient Quality of Life in Cancer Treatment and Improving Access to Biologics
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Improvement of Treatment Environment of Immuno-Oncology Therapy for Urothelial Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Japan
Optimizing the management of mBC HER2-patients / Oncology
Release Date:
Review Process: Expert Review Panel
Quality Improvement Oncology Italy